Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


In Brief: Imagyn Medical Technologies

This article was originally published in The Gray Sheet

Executive Summary

Imagyn Medical Technologies: Consolidation and cost-cutting effort announced Jan. 21 includes plans to close the firm's Laguna Niguel, California plant and move its endoscope manufacturing facility to Costa Mesa. Imagyn will lay off about 120 people as part of the consolidation, which "along with other cost cutting measures" will cut expenditures by about $18 mil. a year, the firm estimates. The move follows the Oct. 1 acquisition of Imagyn Medical by Urohealth Systems ("The Gray Sheet" July 21, 1997, I&W-1) and represents "part of Imagyn's ongoing plan to integrate acquired companies into its mainstream businesses, thereby eliminating redundant staffing and facilities," Imagyn explains. Separately, Imagyn has inked a definitive agreement with International Isotopes that gives Imagyn exclusive worldwide marketing rights to radioactive seeds for treatment of prostate cancer. A March 510(k) submission is anticipated for an initial iodine 125 brachytherapy seed product...

You may also be interested in...

Fragrance Creators Association Launches Online ‘Conservatory’ To Bolster Consumer Confidence

The North American trade organization’s new website offers consumers a gateway into the world of fragrance. Providing a “deep dive” into 50 fragrance ingredients, as well as overviews of perfumery, key regulations, and industry safety practices and sustainability efforts, the site extends FCA’s work to engage and inform consumers at a time of growing interest in manufactured scents.

Vemedia Acquires GSK Brands In Italy, Strikes Deal For GI Product In Spain

GSK has offloaded a further two brands, this time in Italy, giving Netherlands-based Vemedia the opportunity to bolster its portfolio in the country. Vemedia has also added to its offering in Spain by striking a separate deal with Puerto Galiano.

EU Preserves Status Quo On Drugs Under Additional Monitoring

The European Commission has set aside, for now, concerns expressed by member states regarding the scope of medicines subjected to additional monitoring requirements.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts